在严重抑郁症患者中了解初始药物坚持:范围审查
Sourab Ganna1, Javeria Khalid1, Rajender Aparasu1
1Department of Pharmaceutical Health Outcomes and Policy College of Pharmacy, University of Houston, Houston, TX 77204.
Journal of the American Pharmacists Association : JAPhA
|March 5, 2026
概括
大型抑郁症 (MDD) 开始服用药物缺乏一致的定义和测量方法. 标准化方法对于理解初始药物坚持 (IMA) 和改善MDD患者治疗结果至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 最初的药物坚持对于重大抑郁障碍 (MDD) 的成功药物治疗至关重要.
- 药物开始的不一致的定义和测量阻碍了对其对患者结果的影响的理解.
研究的目的:
- 在开始服用抗抑郁药物 (ADM) 的MDD患者中,系统地审查定义,操作化和初始药物坚持度 (IMA) 的测量.
- 识别变异性,并为开发标准化框架的IMA评估提供信息.
主要方法:
- 从PubMed,Embase,Scopus和PsycInfo (开始至2025年3月) 的文献进行范围审查.
- 纳入标准:定义,测量和评估MDD患者启动的研究,处方SSRI或SNRIs.
主要成果:
- 13项研究在最初确定的1,636项研究中满足了纳入标准.
- 在定义 (1填充至6个月的持续时间) 和测量方法 (索赔,自我报告,药丸计数,电子监测) 中发现了显著的变化.
- 观察到缺乏标准化,使坚持状态变得可操作,并观察到不同的坚持值,患者人口统计学和先前的治疗影响了启动.
结论:
- 在定义和测量MDD中的IMA方面存在实质性的异质性.
- 为了改善临床和研究应用,需要整合药理学原理和实时遵守数据的标准化框架.
- 对于一线MDD疗法,需要一个一致的方法来定义,运行和评估IMA.
更多相关视频
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.8K
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
680
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:28Drug Therapy
346
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
346
01:25Antidepressant Drugs: Overview
1.8K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.8K
01:27Depressive Disorders: MDD and Dysthymia
946
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
946
01:26Psychosis: Goals of Pharmacotherapy
646
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
646
01:28Psychosis and Antipsychotic Drugs: Overview
1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K